Biolidics Limited Sustainability Profile
Biolidics Limited, headquartered in Singapore (SG), is a pioneering company in the biotechnology sector, specialising in innovative diagnostic solutions. Founded in 2013, Biolidics has made significant strides in the development of its core products, including its proprietary blood-based diagnostic tests, which are designed to enhance early disease detection and monitoring. With a strong focus on oncology and infectious diseases, Biolidics stands out for its unique microfluidic technology that enables rapid and accurate results. The company has established a notable market position, recognised for its commitment to improving patient outcomes through advanced diagnostics. As it continues to expand its operational reach across Asia and beyond, Biolidics Limited remains at the forefront of the healthcare industry, driving innovation and excellence in diagnostic services.
DitchCarbon Score
How does Biolidics Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biolidics Limited's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biolidics Limited's reported carbon emissions
In 2023, Biolidics Limited reported Scope 2 emissions of approximately 201,500 kg CO2e. This figure represents a slight increase from the previous year, where Scope 2 emissions were about 195,800 kg CO2e in 2022. Notably, Biolidics has not disclosed any Scope 1 or Scope 3 emissions data, indicating a focus primarily on indirect emissions associated with energy consumption. Despite the absence of specific reduction targets or commitments, the company is actively monitoring its carbon footprint. There are currently no climate pledges or initiatives such as Science-Based Targets (SBTi) in place, which suggests that Biolidics may be in the early stages of developing a comprehensive climate strategy. As a company headquartered in Singapore (SG), Biolidics Limited is positioned within an industry increasingly focused on sustainability and carbon reduction. The lack of detailed emissions data and reduction initiatives highlights an opportunity for the company to enhance its climate commitments and align with global sustainability standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 195,800 | 000,000 |
| Scope 3 | - | - |
How Carbon Intensive is Biolidics Limited's Industry?
How Carbon Intensive is Biolidics Limited's Location?
Biolidics Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biolidics Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
